CONTER, VALENTINO

CONTER, VALENTINO  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.063 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 01 - Articolo su rivista 2011 Balduzzi, AGalimberti, SValsecchi, MGBonanomi, SConter, VBiondi, A +
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 01 - Articolo su rivista 2014 BALDUZZI, ADRIANA CRISTINADI MAIO, LUCIABONANOMI, SONIACONTER, VALENTINOBiondi, ACAZZANIGA, GIOVANNI ITALOValsecchi, M +
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia 01 - Articolo su rivista 2014 Conter, VCazzaniga, GValsecchi, MG +
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 01 - Articolo su rivista 2016 PALMI, CHIARACazzaniga, GCONTER, VALENTINO +
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 01 - Articolo su rivista 2016 Valsecchi, MBiondi, ACazzaniga, GConter, V +
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 01 - Articolo su rivista 2016 CONTER, VALENTINOVALSECCHI, MARIA GRAZIARizzari, CCAZZANIGA, GIOVANNI ITALOBIONDI, ANDREA +
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 01 - Articolo su rivista 2016 PALMI, CHIARASAVINO, ANGELA MARIAVILLA, ANTONELLOGAIPA, GIUSEPPEBIONDI, ANDREAVALSECCHI, MARIA GRAZIACONTER, VALENTINOCAZZANIGA, GIOVANNI ITALO +
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 01 - Articolo su rivista 2017 BLANCO LOPEZ, JESSICA GISELLEConter, VRossi, EValsecchi, M +
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 01 - Articolo su rivista 2017 PALMI, CHIARACazzaniga, GCONTER, VALENTINO +
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 01 - Articolo su rivista 2017 MORO, FRANCESCO NICOLO'BIONDI, ANDREACOLOMBINI, ANTONELLACONTER, VALENTINORizzari, C +
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 01 - Articolo su rivista 2018 Cazzaniga, GLeoni, VFerrari, GMConter, ValentinoValsecchi, MGBiondi, A +
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 01 - Articolo su rivista 2018 Cazzaniga, GBiondi, AValsecchi, MGConter, V +
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 01 - Articolo su rivista 2018 Rossi, EmanuelaConter, ValentinoBiondi, AndreaMelzi, Maria Luisa +
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 01 - Articolo su rivista 2018 Biondi, AndreaLeoni, VeronicaCazzaniga, GiovanniConter, ValentinoGrazia Valsecchi, Maria +
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 01 - Articolo su rivista 2018 Biondi, ARizzari, CValsecchi, MGConter, V +
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2018 Galimberti, StefaniaLucenti, AusiliatriceCazzaniga, GiovanniConter, ValentinoBiondi, AndreaValsecchi, Maria Grazia +
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 01 - Articolo su rivista 2019 Biondi, AndreaConter, ValentinoLeoni, VeronicaValsecchi, Maria Grazia +
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 01 - Articolo su rivista 2019 Valsecchi M. G.Rizzari C.Biondi A.Conter V. +
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 01 - Articolo su rivista 2019 Conter V.Mantovani L. +
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 01 - Articolo su rivista 2020 Biondi A.Cazzaniga G.Colombini A.Rizzari C.Valsecchi M. G.Conter V. +